Top Markets
Coin of the day
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Classement en actions #40870
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Prix de l'action
$0.02765
Dernière synchronisation: 2024-12-23
Capitalisation boursière
$69.04K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Histogen Inc. (HSTO)

Catégorie

Historique des divisions d’actions pour Histogen Inc. (HSTO)
L’action Histogen Inc. (symbole : HSTO) a subi un total de 2 divisions.
La division la plus récente a eu lieu le Jun 03, 2022.
Une action HSTO achetée avant le May 27, 2020 équivaudrait aujourd’hui à 0.005 actions HSTO.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
2022-06-03 1:20 x0.05 x0.005
2020-05-27 1:10 x0.1 x0.1
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE